Parallel Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Parallel Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$649K	Sell	13,136 -1,120	-8%	-$56.9K	0.01%	685
2026 Q1	$761K	Buy	14,256 +41	+0.3%	+$2.41K	0.01%	574
2025 Q4	$883K	Sell	14,215 -1,225	-8%	-$75.6K	0.02%	489
2025 Q3	$928K	Sell	15,440 -1,786	-10%	-$109K	0.02%	466
2025 Q2	$1.08M	Sell	17,226 -2,444	-12%	-$147K	0.02%	399
2025 Q1	$1.18M	Sell	19,670 -1,684	-8%	-$105K	0.03%	359
2024 Q4	$1.25M	Sell	21,354 -1,232	-5%	-$73.2K	0.03%	343
2024 Q3	$1.34M	Sell	22,586 -590	-3%	-$33.7K	0.03%	318
2024 Q2	$1.3M	Sell	23,176 -6,612	-22%	-$370K	0.03%	308
2024 Q1	$1.75M	Sell	29,788 -3,554	-11%	-$201K	0.05%	254
2023 Q4	$1.8M	Sell	33,342 -1,145	-3%	-$55.9K	0.05%	223
2023 Q3	$1.67M	Sell	34,487 -6,072	-15%	-$323K	0.06%	218
2023 Q2	$2.29M	Sell	40,559 -9,593	-19%	-$528K	0.07%	189
2023 Q1	$2.71M	Sell	50,152 -8,011	-14%	-$426K	0.09%	168
2022 Q4	$3.06M	Sell	58,163 -22,937	-28%	-$1.16M	0.13%	120
2022 Q3	$3.83M	Sell	81,100 -11,765	-13%	-$610K	0.18%	87
2022 Q2	$4.68M	Sell	92,865 -33,632	-27%	-$1.83M	0.22%	75
2022 Q1	$7.78M	Sell	126,497 -39,591	-24%	-$2.36M	0.31%	56
2021 Q4	$10.9M	Sell	166,088 -115,573	-41%	-$7.4M	0.41%	44
2021 Q3	$17.7M	Sell	281,661 -248,985	-47%	-$15.9M	0.71%	27
2021 Q2	$31.9M	Buy	530,646 +44,478	+9%	+$2.57M	1.35%	13
2021 Q1	$26.8M	Sell	486,168 -20,190	-4%	-$1.12M	1.26%	14
2020 Q4	$27.6M	Buy	506,358 +36,618	+8%	+$1.91M	1.5%	13
2020 Q3	$23.5M	Buy	469,740 +39,600	+9%	+$1.92M	1.45%	14
2020 Q2	$19M	Buy	430,140 +424,620	+7,692%	+$18.1M	1.24%	15
2020 Q1	$207K	Sell	5,520 -606	-10%	-$25.5K	0.02%	432
2019 Q4	$270K	Buy	6,126 +1,206	+25%	+$50.7K	0.02%	419
2019 Q3	$203K	Buy	4,920 +4,800	+4,000%	+$197K	0.02%	467
2019 Q2	$5K	Hold	120	–	–	﹤0.01%	1825
2019 Q1	$5K	Hold	120	–	–	﹤0.01%	1782
2018 Q4	$3K	Buy	+120	New	+$4.16K	﹤0.01%	1740

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Parallel Advisors's IHI Position: Q2 2026 in Review

Parallel Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 7.9% in Q2 2026, selling an estimated $56.9K and leaving 13,136 shares worth $649K. The position accounts for 0.01% of the portfolio, ranked #685.

Parallel Advisors first reported a position in IHI in Q4 2018 and has held it in 31 quarters since. The position peaked at $31.9M in Q2 2021. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Parallel Advisors held 13,136 shares of iShares US Medical Devices ETF worth $649K as of Q2 2026.
Parallel Advisors sold 1,120 iShares US Medical Devices ETF shares in Q2 2026, an estimated $56.9K.
iShares US Medical Devices ETF made up 0.01% of Parallel Advisors's portfolio in Q2 2026, its #685 holding.
Parallel Advisors first reported a position in iShares US Medical Devices ETF in Q4 2018 and has held it in 31 quarters since.
Parallel Advisors's iShares US Medical Devices ETF position peaked at $31.9M in Q2 2021.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.